Overexpression of cannabinoid receptor-interacting protein 1 (CNRIP1) activates Parkin, leading to PKM2 degradation and thereby promoting cell growth and metastasis in intrahepatic cholangiocarcinoma (ICC) (Chen D. et al., 2021). This evidence concerns the gene CNRIP1 and intrahepatic cholangiocarcinoma.